MeSH term
Frequency | Condition_Probility | Animals | 15 | 0.0 |
Child | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 12 | 0.0 |
Female | 45 | 0.0 |
Humans | 60 | 0.0 |
Infant | 2 | 0.0 |
Male | 11 | 0.0 |
Pregnancy | 25 | 0.0 |
Pregnancy Proteins/*metabolism | 11 | 20.0 |
Research Support, Non-U.S. Gov't | 43 | 0.0 |
alpha-Macroglobulins/*metabolism | 5 | 15.0 |
Comparative Study | 12 | 0.0 |
Rats | 2 | 0.0 |
Species Specificity | 3 | 0.0 |
Endopeptidases/*metabolism | 3 | 2.0 |
In Vitro | 3 | 0.0 |
Kinetics | 5 | 0.0 |
LDL-Receptor Related Protein 1 | 8 | 7.0 |
Macromolecular Substances | 5 | 0.0 |
Protein Binding | 9 | 0.0 |
Receptors, Immunologic/*metabolism | 4 | 2.0 |
Chymotrypsin/metabolism | 5 | 13.0 |
Endopeptidases/metabolism | 2 | 1.0 |
Pregnancy Proteins/*chemistry/metabolism | 2 | 66.0 |
Protein Conformation | 9 | 0.0 |
Receptors, Immunologic/metabolism | 3 | 1.0 |
Amino Acid Sequence | 6 | 0.0 |
Binding Sites | 3 | 0.0 |
Chymotrypsin | 2 | 11.0 |
Molecular Sequence Data | 5 | 0.0 |
Trypsin | 2 | 1.0 |
Pregnancy Proteins/isolation & purification/*metabolism | 3 | 75.0 |
Administration, Oral | 2 | 0.0 |
Adult | 7 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
Chromatography, Ion Exchange | 2 | 0.0 |
Methylamines/metabolism | 2 | 10.0 |
Zinc | 2 | 8.0 |
Corticotropin/blood | 2 | 1.0 |
Drug Combinations | 3 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Chromosome Mapping | 2 | 0.0 |
*Chromosomes, Human, Pair 12 | 2 | 0.0 |
Abortion, Threatened/blood | 2 | 33.0 |
Pregnancy/*blood | 3 | 1.0 |
Trophoblastic Neoplasms/blood | 2 | 100.0 |
Uterine Neoplasms/*blood | 2 | 9.0 |
Pregnancy Proteins/*analysis | 5 | 3.0 |
Prospective Studies | 2 | 0.0 |
Rabbits | 3 | 0.0 |
Sex Hormone-Binding Globulin/*analysis | 2 | 0.0 |
Spectrometry, Fluorescence | 3 | 0.0 |
Adolescent | 3 | 0.0 |
Infant, Newborn | 2 | 0.0 |
Ethinyl Estradiol/pharmacology | 2 | 7.0 |
alpha-Macroglobulins/metabolism | 3 | 6.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Mice | 5 | 0.0 |
Chymotrypsin/*metabolism | 3 | 75.0 |
Cloning, Molecular | 2 | 0.0 |
Pregnancy Proteins/*genetics | 2 | 5.0 |
Aged | 4 | 0.0 |
Middle Aged | 7 | 0.0 |
Reference Values | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 4 | 0.0 |
*alpha-Macroglobulins | 2 | 40.0 |
Lymphocyte Activation | 2 | 0.0 |
Antigen-Antibody Complex | 2 | 1.0 |
Molecular Weight | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Gels | 2 | 2.0 |
alpha-Macroglobulins/analysis | 2 | 5.0 |
Chromatography, Affinity | 2 | 0.0 |
alpha-Macroglobulins/*analysis | 2 | 9.0 |
Cross Reactions | 3 | 0.0 |
Immunoelectrophoresis | 3 | 1.0 |
Estrone/blood | 2 | 2.0 |
Sex Hormone-Binding Globulin/analysis | 2 | 0.0 |
Administration, Topical | 2 | 1.0 |
Liver/metabolism | 2 | 0.0 |
Chemistry, Physical | 2 | 1.0 |
Menopause/*drug effects | 2 | 28.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Lymphocyte Culture Test, Mixed | 2 | 0.0 |
Immunoelectrophoresis, Two-Dimensional | 2 | 1.0 |
Pregnancy Trimester, Third | 2 | 1.0 |
Haplorhini | 2 | 0.0 |
*Pregnancy | 4 | 2.0 |
Placental Lactogen/metabolism | 2 | 11.0 |